• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Needle free diabetes care Market

    ID: MRFR/MED/17918-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Needle Free Diabetes Care Market Research Report –Forecast 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Needle free diabetes care Market Infographic
    Purchase Options

    US Needle free diabetes care Market Summary

    The US Needle Free Diabetes Care market is projected to grow significantly, reaching 6500 USD Million by 2035 from a base of 2500 USD Million in 2024.

    Key Market Trends & Highlights

    US Needle Free Diabetes Care Key Trends and Highlights

    • The market is valued at 2500 USD Million in 2024 and is expected to expand to 6500 USD Million by 2035.
    • The compound annual growth rate (CAGR) for the market is projected at 9.07% from 2025 to 2035.
    • This growth trajectory indicates a robust demand for innovative diabetes management solutions in the US.
    • Growing adoption of needle-free technology due to patient preference for less invasive procedures is a major market driver.

    Market Size & Forecast

    2024 Market Size 2500 (USD Million)
    2035 Market Size 6500 (USD Million)
    CAGR (2025 - 2035) 9.07%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Needle free diabetes care Market market include

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.42(USD Billion)
    MARKET SIZE 2024 1.5(USD Billion)
    MARKET SIZE 2035 3.2(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.131% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED AstraZeneca, Merck, Eli Lilly, Medtronic, Dexcom, Boehringer Ingelheim, Novo Nordisk, Insulet, Johnson and Johnson, Amgen, Roche, Tandem Diabetes Care, Sanofi, Abbott, GSK
    SEGMENTS COVERED Type, Test, Devices, Treatment
    KEY MARKET OPPORTUNITIES Telehealth diabetes management solutions, Continuous glucose monitoring technology, Personalized diabetes treatment plans, Education and support services expansion, Digital health apps for self-management
    KEY MARKET DYNAMICS rising diabetes prevalence, increasing healthcare costs, advancements in treatment technologies, growing demand for remote monitoring, government initiatives for diabetes management
    COUNTRIES COVERED US
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials